Literature DB >> 26334969

[Psychotherapeutic procedures for fibromyalgia syndrome].

W Häuser1, K Bernardy.   

Abstract

BACKGROUND: Psychosocial factors play an important role in the predisposition, triggering and course of fibromyalgia syndrome (FMS). Cognitive behavioral therapies are strongly recommended in the current guidelines on the management of FMS in Canada, Germany and Israel. AIMS: Review of techniques, aims and efficacy of psychotherapeutic procedures in FMS.
MATERIAL AND METHODS: Narrative review based on a selective search for systematic reviews on the efficacy of psychotherapeutic procedures in FMS.
RESULTS: There is robust evidence for the short and long-term efficacy of cognitive behavioral therapies on some key symptoms of FMS, e.g. pain, depression and disability. The quality and quantity of the evidence for the efficacy of other psychotherapeutic procedures (e.g. biofeedback, relaxation therapies, hypnosis/guided imagery and psychodynamic therapy) are insufficient.
CONCLUSION: Cognitive behavioral therapies (e.g. acceptance and commitment therapy, cognitive behavioral therapy and operant therapy) should play an important role in a graduated and individually tailored therapy of FMS patients.

Entities:  

Mesh:

Year:  2015        PMID: 26334969     DOI: 10.1007/s00393-014-1555-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

1.  [Physicians do not treat averages--but therapy responders!].

Authors:  C Maier; R Baron
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

2.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 3.  Efficacy and effectiveness of cognitive behaviour therapy for chronic pain: Progress and some challenges.

Authors:  Stephen Morley
Journal:  Pain       Date:  2010-12-14       Impact factor: 6.961

4.  Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials.

Authors:  Winfried Häuser; Kathrin Bernardy; Bernhard Arnold; Martin Offenbächer; Marcus Schiltenwolf
Journal:  Arthritis Rheum       Date:  2009-02-15

Review 5.  [Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  V Köllner; W Häuser; K Klimczyk; H Kühn-Becker; M Settan; M Weigl; K Bernardy
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

6.  [Potentialities and limitations of hypnosis for the treatment of pain].

Authors:  B Peter
Journal:  Schmerz       Date:  1998-07-10       Impact factor: 1.107

7.  Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial.

Authors:  R K Wicksell; M Kemani; K Jensen; E Kosek; D Kadetoff; K Sorjonen; M Ingvar; G L Olsson
Journal:  Eur J Pain       Date:  2012-10-23       Impact factor: 3.931

8.  [Predictors of successful transfer to everyday live of a relaxation method acquired in psychosomatic rehabilitation].

Authors:  K Bernardy; G Krampen; V Köllner
Journal:  Rehabilitation (Stuttg)       Date:  2008-12-15       Impact factor: 1.113

9.  Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome.

Authors:  Kati Thieme; Dennis C Turk; Herta Flor
Journal:  Arthritis Rheum       Date:  2007-06-15

Review 10.  Cognitive behavioural therapies for fibromyalgia.

Authors:  Kathrin Bernardy; Petra Klose; Angela J Busch; Ernest H S Choy; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10
View more
  1 in total

1.  [Treatment of fibromyalgia syndrome with gamma-hydroxybutyrate : A randomized controlled study].

Authors:  E Reuter; S Tafelski; K Thieme; C West; U Haase; L Beck; M Schäfer; C Spies
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.